Nilsine Partners
AMGN icon

Nilsine Partners’s Amgen AMGN Stock Holding History

Nilsine Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.91M Buy
9,273
+80
+0.9% +$31.9K 0.27% 87
2026
Q2 		$3.33M Buy
+9,193
New +$3.15M 0.23% 105
2024
Q4 		– Sell
-694
Closed -$224K – 364
2024
Q3 		$224K Sell
694
-53
-7% -$17.3K 0.03% 322
2024
Q2 		$233K Buy
+747
New +$219K 0.03% 304

Other funds holding AMGN

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Nilsine Partners's AMGN Position: Q3 2026 in Review

Nilsine Partners increased its Amgen (AMGN) stake by 0.87% in Q3 2026, buying an estimated $31.9K and bringing the position to 9,273 shares worth $3.91M. The position accounts for 0.27% of the portfolio, ranked #87.

Nilsine Partners first reported a position in AMGN in Q2 2024 and has held it in 4 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Nilsine Partners held 9,273 shares of Amgen worth $3.91M as of Q3 2026.
  • Nilsine Partners bought 80 Amgen shares in Q3 2026, an estimated $31.9K.
  • Amgen made up 0.27% of Nilsine Partners's portfolio in Q3 2026, its #87 holding.
  • Nilsine Partners first reported a position in Amgen in Q2 2024 and has held it in 4 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Nilsine Partners's 13F filing for Q3 2026, filed 2 Nov 2026.